- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05948800
Impact of Nasal Isotonic Solution Irigation on Healthy Athletes' Nasal Flow and Nasal Obstruction Exercise Outcomes (ISOtastic!)
Effect of Isotonic Seawater Solution on Nasal Patency in Athletes: an Interventional Randomized Prospective Cohort Study
Nasal patency is an important component of performing exercises because it helps in humidifying, heating and filtering the inhaled air. However, many athletes and exercisers experience difficulty breathing through their nose, which can affect their breathing and performance. Namely, during sports activities and greater physical effort, there is increased air flow, which causes significant dehydration and cooling of the mucous membrane of the upper respiratory system. This dehydration is associated with the release of inflammatory mediators, which can ultimately lead to narrowing of the airways (eg in athletes with asthma). However, in all athletes, regardless of whether they have asthma or not, damage to the airways can occur because during exercise, hyperpnea exposes the respiratory epithelium to increased physical forces and pressure, which leads to the risk of exfoliation of the previously dehydrated epithelial cells of the nose and even their complete separation. Repeated stretching and compression can negatively affect the functionality of the epithelium and, with repeated exposure and damage, lead to structural and functional changes.
Rinsing the nose with a hypertonic or isotonic solution of seawater is a potential solution for nasal obstruction because after rinsing, the airflow through the nose improves and symptoms of obstruction are reduced. However, the effects of using nasal lavage solutions along with exercise in elite athletes are not yet known. The potential synergy of exercise and isotonic seawater solution as a nasal spray on airflow and the subjective impression of nasal patency in healthy individuals has not been sufficiently investigated5.
Research question
What is the effect of an isotonic seawater solution applied as a nasal spray on nasal airflow and the subjective impression of nasal obstruction in healthy athletes?
Hypothesis
An isotonic seawater solution applied as a nasal spray will improve nasal airflow and the subjective impression of nasal obstruction in healthy athletes.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Subjects and Methods
Participants:
50 healthy adult athletes between the ages of 18 and 35 will be engaged in the research (power analysis with 80% power and an alpha error of 5% shows that 32 subjects in two groups are sufficient).
Exclusion criteria: Bacterial or viral acute inflammation of the upper respiratory system, chronic obstruction of one or both nostrils with significant deformation of the septum, surgery on the nose or nasal septum within one month of the start of the study
Isotonic seawater:
product from the market, Aqua Maris nasal spray (manufacturer JGL, Rijeka), applied in accordance with the approved Instructions for Consumers
Study design:
A randomized, interventional prospective cohort study.
Intervention:
The participants will be divided into two groups using the binary coin-toss method (random.org) with similar physical and demographic characteristics. The first group will use an isotonic seawater solution as a nasal spray for 10 days, while the control group will not use such a solution. The group with the isotonic seawater solution applied as a nasal spray will use it at least three times a day, and necessarily before exercise (about 20 minutes before).
Outcome measures:
The primary outcome measures will be nasal airflow measured with a peak nasal inspiratory flow meter (PNIF) and subjective impression of nasal obstruction symptoms before and after exercise by completing the NOSE questionnaire. The NOSE contains five statements about nasal obstruction, divided on a 4-point Likert scale for each statement.
Remark:
PNIF meters will be provided by JGL (measurement with them takes < 1 min/athlete) The NOSE questionnaire (abbreviated from Nasal Obstruction Symptom Evaluation) is an internationally recognized and validated scale for assessing the intensity of nasal obstruction.
The time points for the collection of measures will be:
Day 1: before the start of the research, before the first training session (first interval), respectively:
- NOSE
- PNIF
Day 1: after the first use of the spray, (within 20 minutes after the first training session - second interval), i.e. after the first training session in the control group, respectively:
- NOSE
- PNIF
Day 7: after ten days of daily use of the spray, after training (third interval) or after the first training in the control group, respectively:
- NOSE
- PNIF
Data analysis:
- Descriptive statistics and inferential statistics will be used to compare outcomes between two groups (no less than 16 participants in the nasal spray group vs. no less than 16 participants without the spray).
- Each couple from the test group will be joined by a couple from the control group with as similar physical and demographic characteristics as possible.
The Wilcoxon signed rank test and the Friedman test for paired samples will be used depending on the distribution of the data.
Ethical considerations This study will be conducted in accordance with ethical principles and guidelines (1996 Helsinki Declaration, in accordance with current Croatian regulations, and after approval by the competent hospital ethics committee). Written informed consent will be obtained from all participants.
Participants will be informed of the risks and benefits of the study by the examining physician. The confidentiality of the participant's data will be ensured in such a way as to comply with GDPR provisions in accordance with EU and national legislation.
Conclusion
This study aims to investigate the effects of an isotonic solution of seawater from the Adriatic Sea applied as a nasal spray on:
- subjective nasal patency
- nasal airflow in healthy athletes.
The results of this research could help athletes improve performance by improving nasal airflow and nasal function.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zagreb, Croatia, 10000
- Recruiting
- University Hospital Center Sestre milosrdnice
-
Contact:
- Ana Gašić, MD
- Phone Number: +385996879905
- Email: anagasic4@gmail.com
-
Contact:
- Andro Košec, MD, PhD
- Phone Number: +385989817156
- Email: andro.kosec@yahoo.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 50 healthy adult athletes between the ages of 18 and 35 will be engaged in the research (power analysis with 80% power and an alpha error of 5% shows that 32 subjects in two groups are sufficient).
Exclusion Criteria:
- Bacterial or viral acute inflammation of the upper respiratory system, chronic obstruction of one or both nostrils with significant deformation of the septum, surgery on the nose or nasal septum within one month of the start of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Spraying group
The first group will use an isotonic seawater solution as a nasal spray for 10 days.
The group with the isotonic seawater solution applied as a nasal spray will use it at least three times a day, and necessarily before exercise (about 20 minutes before).
|
Isotonic sea water: product from the market, Aqua Maris nasal spray (manufacturer JGL, Rijeka), applied in accordance with the approved Instructions for Consumers.
|
|
No Intervention: Non-spraying group
The control group will not use such a solution.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak nasal inspiratory flow
Time Frame: Prior to excercise, on the first day after training and on the seventh day after training.
|
The primary outcome measures will be nasal airflow measured with a peak nasal inspiratory flow meter (PNIF).
|
Prior to excercise, on the first day after training and on the seventh day after training.
|
|
NOSE questionnaire
Time Frame: Prior to excercise, on the first day after training and on the seventh day after training.
|
Subjective impression of symptoms of nasal obstruction before and after exercise by completing the NOSE questionnaire.
The NOSE contains five statements about nasal obstruction, divided on a 4-point Likert scale for each statement.
|
Prior to excercise, on the first day after training and on the seventh day after training.
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EP 25I-29-II13-23-03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nasal Obstruction
-
Aerin MedicalNot yet recruitingNasal Airway Obstruction
-
Saglik Bilimleri UniversitesiCompletedNasal Obstruction Septal Deviation Compensatory Inferior Turbinate HypertrophyTurkey (Türkiye)
-
BayerRecruitingNasal Obstruction | Nasal CongestionCanada
-
Cumhuriyet University HospitalRecruitingNasal Obstruction | Rhinoplasty | Nasal DeformityTurkey (Türkiye)
-
Spirair, IncActive, not recruitingNasal Airway Obstruction | Nasal Septal DeviationUnited States
-
Aerin MedicalOhio State UniversityCompletedNasal ObstructionUnited States
-
Aerin MedicalCompletedNasal Airway ObstructionUnited States
-
Yuzuncu Yıl UniversityCompleted
-
Aerin MedicalCompletedNasal ObstructionUnited States
-
Aerin MedicalActive, not recruiting
Clinical Trials on Nasal irrigation with seawater isotonic solution
-
Slagelse HospitalZealand University Hospital; Copenhagen University Hospital at Herlev; Holbaek... and other collaboratorsNot yet recruitingAsthma in Children | Bronchiolitis | Respiratory Disease | Acute Respiratory Infection | Viral Infection
-
Istanbul Medeniyet UniversityCompletedNasal Congestion | NursingTurkey
-
Ain Shams UniversityCompletedHypertonic Saline | Distilled Water | Irrigation | Normal Saline | Bladder (Urothelial, Transitional Cell) Cancer | Nonmuscle Invasive Bladder CancerEgypt
-
Gadjah Mada UniversityEnrolling by invitationAllergic Rhinitis | Allergic Rhinitis Due to House Dust MiteIndonesia
-
Vanderbilt University Medical CenterCompleted
-
YSLabNot yet recruitingSinusitis | Rhinitis | Upper Respiratory Infections | Colds
-
Lallemand Pharma AGCompleted
-
University of Wisconsin, MadisonCompletedFatigue | Chronic Sinusitis | Persian Gulf Syndrome | Acute SinusitisUnited States
-
Associazione Infermieristica per lo studio delle...B. Braun Medical SACompletedPressure Ulcer | Wound Cleansing | Chronic Wound CareItaly
-
NHS GrampianUnknownNasal SurgeryUnited Kingdom